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Abstract Antiinﬂammatory effects of phenolic com-
pounds from Emblica ofﬁcinalis were evaluated in
carrageenan and cotton pellet induced acute and chronic
inﬂammatory animal model. Fractions of E. ofﬁcinalis
containing free (FPEO) and bounded (BPEO) phenolic
compounds were assessed by HPLC technique. The free
and bound phenolic compounds were studied for their
acute and chronic antiinﬂammatory activity at dose level
of 20 and 40 mg/kg. The carrageenan induced acute
inﬂammation was assessed by measuring rat paw volume
at different time of intervals. Further, cotton pellet
induced chronic inﬂammation was assessed by granu-
lomatous tissue mass estimation along with the
estimation of tissue biomarker changes (i.e. lipid perox-
idation, reduced glutathione, myeloperoxidase and plasma
extravasation). The results indicated that in both acute
and chronic inﬂammation, FPEO and BPEO show
reduction in the inﬂammation, but signiﬁcant effects was
observed only at high doses of both fractions which was
comparable to diclofenac treated group. In conclusion,
phenolic compounds of E. ofﬁcinalis may serve as
potential herbal candidate for amelioration of acute and
chronic inﬂammation due to their modulatory action of
free radicals.
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Introduction
Emblica ofﬁcinalis (E. ofﬁcinalis), syn: Phyllanthus emb-
lica, also known as amla belongs to the Euphorbiaceae
family. E. ofﬁcinalis has been reported to possess potential
antioxidant effect (Liu et al. 2008). The fruits of amla are
used in many medicinal preparations of Ayurvedic and
Unani systems of medicine (Kirtikar and Basu 1933). It is
also used to treat haemorrhage, diarrhoea and dysentery
(Charaka 1941). In folk medicine, all parts of the plant,
including fruit, seed, leaf, root, bark and ﬂower are used in
various Ayurvedic/Unani herbal preparations (Habib-ur-
Rehman et al. 2007).
Amla is highly nutritious and could be important dietary
source of vitamin C, minerals and amino acids. It also
contains phenolic compounds, tannins, phyllembelic acid,
phyllemblin, rutin, curcuminoides and emblicol (Zhang
et al. 2000; Jeena et al. 2001). Singh and Sharma (1971)
found that amla was effective in gastric syndromes. The
therapeutic efﬁcacy of amla in case of dyspepsia was
evaluated (Chawla et al. 1982) with promising results in
human subjects. Raw E. ofﬁcinalis fruit is also used for
making pickle and preservatives (Ahumada et al. 1989;
Deokar 1998; Perry and Metzger 1980). The pharmaco-
logical studies shown that amla fruit was able to lower the
lipid level in the liver of rabbits. It was also used as an
antimicrobial (Rani and Khullar 2004), antitumor (Jeena
et al. 2001), antipyretic and analgesic agent (Perianayagam
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123et al. 2004; Sharma et al. 2003) as well as has shown
hypoglycemic activity. It has also been found to possess
potential effect on glucose intolerance, cerebral insufﬁ-
ciency, mental disorders, etc (Nadkarni 1976; Anila and
Vijayalakshmi 2002).
Carrageenan induced hind paw inﬂammation is a
neutrophil-mediated acute inﬂammatory response that
produces hind paw swelling, erythema and localized
hyperthermia (Leung et al. 2001; Tsuji et al. 2003).
Inﬂammation and tissue injury lead to enhanced pain sen-
sitivity (hyperalgesia), which in part is caused by altered
plasticity in the spinal cord (Dubner and Ruda 1992; Woolf
and Costigan 1999). Free radicals play an important role in
the pathogenesis of inﬂammation (Di Rosa et al. 1971;
Koblyakov 2001; Sood et al. 2009).
Moreover, E. ofﬁcinalis has attracted the attention of
researchers as it was found to be an interesting source of
phenolic compounds, which include phenolic acids and
ﬂavonoids (Suresh Kumar et al. 2006). E. ofﬁcinalis leaf
extract possesses antiinﬂammatory action (Asmawi et al.
1993; Ihantola-Vormisto et al. 1997), but fruit extract
containing free and bound phenolic constituents has not
been explored yet. Therefore, in the present study, we
present the role of free and bound phenolic compounds
of E. ofﬁcinalis in acute and chronic inﬂammation in
rats.
Materials and methods
Animals
Sprague-Dawley rats (180–250 g) were procured from
Panjab University, Chandigarh. The animals were housed
under standard conditions of natural 12 h light and dark
cycle with free access to food pellets (Hindustan Lever
Products, Kolkata, India) and water. The experimental
protocol was duly approved by Institutional Animal Ethics
Committee (IAEC) and care of the animals was carried out
according to the guidelines of ‘‘Committee for the Purpose
of Control and Supervision of Experiments on Animals’’
(CPCSEA), Government of India (Reg No. 874/ac/05/
CPCSEA).
Chemicals
Malondialdehyde (MDA), Folin’s phenol reagent, 5,5-
dithiobis (2-nitro benzoicacid) (DTNB), 1-chloro 2,4-
dinitrobenzene (CDNB) and reduced glutathione were
purchased from SISCO Research Laboratories Pvt. Ltd.
(Mumbai, India). Carrageenan and diclofenac were
obtained from Sigma-Aldrich, USA. All other chemicals
used in the experiments were of analytical grade.
Plant materials
Isolation of free phenolic compounds
Free phenolic compounds of E. ofﬁcinalis were isolated
according to the method of Subba Rao and Murlikrishna
(2002). E. ofﬁcinalis fruit powder (1 g) was extracted three
times using 70% ethanol (350 mL, 2 h each). The com-
bined extracts were ﬁltered, centrifuged at 3,000 g for
15 min and supernatant was concentrated under reduced
pressure. The pH was adjusted to 1.5 with hydrochloric
acid (4 N). Phenolic acids were separated by ethyl acetate
phase separation (450 mL) and the pooled fractions
were treated with anhydrous sodium sulfate, ﬁltered and
evaporated to dryness. Total phenolic acid content was
estimated spectrophotometrically at 760 nm by Folin–
Ciocalteu method with gallic acid as the reference standard
and expressed as gallic acid equivalent in milligrams per
gram of dry weight sample. Total ﬂavonoid content was
determined spectrophotometrically at 358 nm by the alu-
minum chloride method with rutin as a reference standard
and expressed as rutin equivalent in microgram per gram of
dry weight sample. The presence of tannins was deter-
mined spectrophotometrically at 760 nm by the reduction
of phosphotungstomolybdic acid method with tannic acid
as a reference standard and expressed as tannic acid
equivalent in milligram per gram of dry weight sample.
Isolation of bound phenolic compounds
Emblica ofﬁcinalis extract as prepared above (2 g) was
defatted with petroleum ether and chloroform (1:1, v/v) and
free phenolic acids were extracted with 70% ethanol
(450 mL). The dried samples were extracted with sodium
hydroxide (1 M, 2,100 mL) containing 0.5% sodium
borohydride and the clear supernatants were collected by
centrifugation (Nordkvist et al. 1984). The combined
supernatants (bound phenolics) were acidiﬁed with
hydrochloric acid (4 N) to pH 1.5. The phenolic acids were
extracted and quantiﬁed colorimetrically in the same way
as free phenolic acids.
Characterization of free and bound phenolics compounds
of E. ofﬁcinalis
The active phenolic components of E. ofﬁcinalis extract as
prepared above were characterized using HPLC technique
(model AKAD06532, Cyberlab Corporation, USA) on a
reverse phase C18 column (4.6 9 250 mm) using a diode
array UV detector (operating at 275 nm). A solvent system
consisting water: acetic acid: methanol (isocratic 80:5:15,
v/v) was used as mobile phase at a ﬂow rate of 1 mL/min.
In addition, a gradient solvent system (solvent A—water:
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nol; 0–100% gradient; run time—5 min; ﬂow rate: 1.0 mL/
min) were used to resolve ascorbic acid, gallic and tannic
acid peaks in the sample. Standard phenolic acids such as
caffeic, ferulic, gallic, tannic and vanillic acid along with
ascorbic acid were used for the identiﬁcation of phenolic
components present in both free and bound phenolic frac-
tions of E. ofﬁcinalis.
Carrageenan induced paw oedema
The paw oedema was induced in rats by 0.1 mL of 1 per-
centage of carrageenan in saline injecting subcutaneously in
the subplantar region of left hind paw, 1 h after the
administration of test samples (Brich et al. 1992). The test
samples FPEO and BPEO were administered at low and
high doses (20 and 40 mg/kg, p.o.). Diclofenac (25 mg/kg,
p.o.) was used as a reference drug. The paw volumes of rats
were measured by plethysmometer, before and after injec-
tion of 1% carrageenan at different time intervals (0.5, 1, 2,
4, 8, 16, and 24 h). Changes in paw volume were recorded
at the above-mentioned time intervals.
Experimental design
Seven groups were employed in the present antiinﬂam-
matory study. Each group consists of six rats.
Group I (vehicle control group): 1% of carboxy methyl
cellulose (1 mL, p.o.) was administered to the rats.
Group II (negative control group): 0.1 mL of 1 per-
centage of carrageenan in saline was administered
subcutaneously to the rats on the day of the experiment.
Group III (positive control group): diclofenac sodium
(12.5 mg/kg, p.o.) was administered before 1 h of the
carragennan administration.
Groups IV–VII (test groups): rats were pretreated with
free and bound phenolic compounds of E. ofﬁcinalis (20
and 40 mg/kg, p.o.) for six consecutive days. On the sixth
day, carrageenan was administered to the rats, after 1 h
from the test compounds administration.
Cotton pellet induced granuloma tissue formation
FPEO, BPEO and diclofenac sodium were orally admin-
istered for 16 consecutive days in Groups III–VII. On
eighth day, the animals (Groups II–VII) were mildly
anaesthetised with ether, four sterile cotton pellets (50 mg)
were subcutaneously implanted in the dorsal region of the
rats and two at the axilla and two at the groin regions. On
16th day, all the rats were killed using anaesthetic ether and
the cotton pellets were dissected out without affecting the
surrounding granuloma tissues (Winter and Porter 1957).
Chronic inﬂamed tissues (from axilla and groin regions)
were excised and stored in 0.9% saline at -20C for bio-
chemical analysis. The moist pellets were weighed and
then dried at 60C for 48 h and then again reweighed. The
percentage reduction in cotton pellet’s weight of the test
samples was observed and compared with that of respec-
tive cotton pellet and diclofenac sodium treated groups.
This provides a measure to assess the antiinﬂammatory
effect of the test samples.
Experimental design
Seven groups were employed in the present antiinﬂam-
matory study. Each group consists of six rats and
experimental protocol included 16 days study. Each group
of animals was employed with sterile cotton pellets (50 mg
each) implantation in the dorsal region of rats at eighth day.
Group I (vehicle control group): 1% of carboxy methyl
cellulose (1 mL, p.o.) was administered to the rats for 16
consecutive days.
Group II (negative control group): four sterile cotton
pellets, 50 mg each were implanted in the dorsal region of
rats at eighth day.
Group III (positive control group): reference standard
drug and diclofenac sodium (12.5 mg/kg, p.o.) were
administered to the rats for 16 consecutive days.
Groups IV–VII (test groups): rats were pretreated with
free and bound phenolic compounds of E. ofﬁcinalis (20
and 40 mg/kg, p.o.) for 16 consecutive days.
Biochemical analysis
At the end of the study (i.e. 16th day), samples from
granulomatous tissue were evaluated for the inﬂammatory
and oxidative stress markers.
Estimation of total protein content
The protein concentration was estimated according to the
method of Lowry et al. (1951). The protein content was
determined spectrophotometrically at 750 nm using bovine
serum albumin as a standard. Total protein content was
expressed as milligram per gram of tissue.
Estimation of thiobarbituric acid reactive substances
Thiobarbituric acid reactive substances (TBARS; as an
index of lipid peroxidation) were estimated according to
the method of Ohkawa et al. (1979). The absorbance was
measured spectrophotometrically at 532 nm. A standard
calibration curve was prepared using 1–10 nM of 1, 1, 3, 3-
tetra methoxy propane. TBARS value was expressed as
nanomoles per gram of protein.
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The reduced glutathione (GSH) content in tissue was
estimated using method of Ellman (1959). Absorbance was
noted spectrophotometrically at 412 nm. A standard curve
was plotted using 5–50 lM of reduced form of glutathione
and the results were expressed as micrograms of reduced
glutathione per gram of protein.
Estimation of myeloperoxidase activity
The myeloperoxidase (MPO) activity was estimated
according to the method of Hillegass et al. (1990). The
presence of MPO was measured at 460 nm for 3 min. MPO
activity was expressed as unit per gram protein per minute.
One unit of MPO activity was deﬁned as that degrading
1 lmol peroxide per min at 25C.
Evaluation of changes in vascular permeability
The amount of Evans blue in tissue samples was quantiﬁed
according to the method described by Lange et al. (1994).
Animals were injected with 1 mL of Evans blue (2 mg/kg)
via the tail vein 30 min before sacriﬁce using anaesthetic
ether. Evans blue was extracted from the tissues with 4 mL
of formamide for 24 h at 50C. The absorbance was
measured at 620 nm. A standard calibration curve was
prepared using Evans blue (0.1–1 lg) diluted with form-
amide. Vascular permeability was expressed as amount in
microgram of Evans blue per milligram of protein.
Statistical analysis
All the results were expressed as mean ± standard error of
means (SEM). The data from the carrageenan induced paw
oedema was statistically analyzed by two-way analysis of
variance followed by Bonferonni’s post test using Graph
pad prism Version-5.0 software. The data from the cotton
pellet induced granuloma tissue formation and biochemical
results were statistically analyzed by one-way analysis
of variance (ANOVA) followed by Tukey’s multiple
range tests using Sigmastat Version-2.0 software and the
p\0.05 was considered to be statistically signiﬁcant.
Results
Identiﬁcation of free and bound phenolic compounds
of E. ofﬁcinalis
As previously reported, standardized HPLC protocol was not
supported by separation of phenolic acids under isocratic
elution condition (Duke 1992; Suresh Kumar et al. 2006).
Therefore, we have optimized gradient running system;
ascorbicacidwasseparatedwithawiderangeofretentiontime
(i.e., 1.79 min) relative to that of gallic acid and tannic acid,
which eluted at 2.36 min. Moreover, tannic acid (319.4 lg/g
ofextract)andgallic acid (104.6 lg/gofextract) components
have not been separated with this condition, but presence of
this compounds identiﬁed by peak coincidence with the
retention time of standard gallic and tannic acid. It was also
revealed that there was absence of ascorbic acid in both free
and bound phenolic fractions of E. ofﬁcinalis (Fig. 1).
Effect of E. ofﬁcinalis on carragennan induced paw
oedema
The effect of phenolic compounds of E. ofﬁcinalis on carr-
agennan induced paw oedema was measured by the changes
inlefthindpawvolumeoftheratsaspresentedinFigs. 2and
3. The paw volume was found to increase as compare to
vehicle control group in the carrageenan treated group
whereas, diclofenac sodium (12.5 mg/kg) pretreated group
have shown decrease in the paw volume as compared to
carrageenan treated group. Pretreatment with FPEO and
BPEO reduced the carrageenan induced inﬂammation as
indicated by decrease in paw volume. However, only high
dose (40 mg/kg) of both fractions have shown signiﬁcant
(p\0.05) antiinﬂammatory response which was compara-
ble to the diclofenac sodium pretreated group.
Effect of E. ofﬁcinalis on granulomatous tissue
formation
Table 1 shows the effect of FPEO and BPEO on granu-
lomatous tissue changes due to cotton pellet induced
chronic inﬂammation. Changes in the cotton pellets weight
(wet weight–dry weight) of the test samples were com-
pared with the cotton pellet and diclofenac sodium
(12.5 mg/kg) treated groups. Pretreatment (i.e. on days
1–8) of diclofenac and the phenolic fractions of E. ofﬁci-
nalis did not show any behavioral changes. Both the
fractions have shown reduction in granulomatous tissue
mass as compared to cotton pellet treated group. However,
only high doses (40 mg/kg) of each fraction have shown
signiﬁcant (p\0.05) reduction which was comparable to
that of diclofenac sodium pretreated group.
Effect of E. ofﬁcinalis on tissue biomarker changes
Effects of FPEO and BPEO on biomarker changes due to
cotton pellet induced chronic inﬂammation are shown in
Table 2. In the cotton pellet treated group; TBARS, MPO
and plasma extravasation levels were found to increase
whereas, GSH level was found to decrease as compare to
normal control group. However, diclofenac sodium, pre-
treatment of FPEO and BPEO groups ameliorated the
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fractions have shown signiﬁcant (p\0.05) ameliorative
effect on the biomarker changes which were comparable to
that of diclofenac sodium treated group.
Discussion
In this study, antiinﬂammatory effects of E. ofﬁcinalis
containing free and bound phenolic compounds were
evaluated in carrageenan induced acute and cotton pellet
induced chronic inﬂammation in Sprague-Dawley rats.
Phenolic fractions of E. ofﬁcinalis signiﬁcantly reduced
paw volume in acute inﬂammation. Further, in chronic
inﬂammatory condition, free and bound phenolic com-
pounds containing fractions were found to decrease the
granulomatous tissue mass, cotton pellet induced granu-
loma tissue lipid peroxidation, myeloperoxidase activity
and plasma extravasation whereas, there was a rise in the
tissue reduced glutathione levels. However, signiﬁcant
effect was observed at high doses of both fractions.
Fig. 1 HPLC proﬁle of free and
bound phenolic fractions of E.
ofﬁcinalis. HPLC peak in I (a, b,
c) indicates standard ascorbic
acid (RT 1.63), tannic acid (RT
2.41) and gallic acid (RT 2.59),
respectively. Further, peaks in II
and III indicate the presence of
tannic and gallic acid in both,
free and bound phenolic fraction
of E. ofﬁcinalis, respectively
Fig. 2 Effect of FPEO on carrageenan induced paw oedema. Time
course of paw oedema was measured by the carrageenan induced
increased paw volume in rats. DCL Diclofenac sodium, FPEO Free
phenolic compounds of E. ofﬁcinalis. Data were expressed as
mean ± SEM, n = 6 rats per group. ap \0.05 versus vehicle
control groups, bp \0.05 versus carrageenan treated group and c
p\0.05 versus diclofenac sodium control group
Fig. 3 Effect of BPEO on carrageenan induced paw oedema. Time
course of paw oedema was measured by the carrageenan induced
increased paw volume in rats. DCL Diclofenac sodium, BPEO Bound
phenolic compounds of E. ofﬁcinalis. Data were expressed as
mean ± SEM, n = 6 rats per group. ap \0.05 versus vehicle
control groups, bp \0.05 versus carrageenan treated group and c
p\0.05 versus diclofenac sodium control group
E. ofﬁcinalis on tissue inﬂammation 331
123Potential acute and chronic antiinﬂammatory activities
were found in the both the fractions at high dose level
(FPEO and BPEO). Further, in HPLC analysis, it was
revealed that free phenolic contents of E. ofﬁcinalis were
three times more than that of bound form. Both phenolic
fractions of E. ofﬁcinalis are consisting of gallic and tannic
acid. Phenolic fractions are also known to posses various
secondary metabolites, such as ﬂavonoids and phenolic
acids, etc., that are well known to posses highest antioxi-
dant activity (Arumugam et al. 2006). It may support the
effect of FPEO and BPEO on suppression of the granu-
lomatous tissues formation and free-radical scavenging
activity resulted in fall in cotton pellet induced granuloma
tissue TBARS and MPO activity, plasma extravasation and
rise in GSH level due to the presence of pharmacological
active moiety, such as ﬂavonoids and other phenolic
compounds (Arumugam et al. 2006; Suleyman et al. 2003).
Moreover, ﬂavonoids have been reported to inhibit the
cyclooxygenase and lipooxygenase pathways of arachido-
nate metabolism (Pelzer et al. 1998; Zheng et al. 2003).
The inﬂammatory process was reported to be associated
with the generation of reactive oxygen species (ROS) and
reactive nitrogen species (RNS) (Jung et al. 2005).
Recently, literature reveals that E. ofﬁcinalis found to
posses the phenolic compounds, i.e. ﬂavonoids, phenolic
acids, etc. (Suresh Kumar et al. 2006). Phenolic compounds
(i.e. gallic acid, tannic acid, etc.) are having strong anti-
oxidant action (Cuvrelier et al. 1992; Subba Rao and
Murlikrishna 2002). It is also evident that phenolic com-
pounds obtained from natural source may reduce oxidative
stress by free-radical scavenging activity (Liu et al. 2008;
Vinson et al. 1998). Further, leaf extract of E. ofﬁcinalis is
Table 1 Effect of E. ofﬁcinalis on wet and dry weight changes in cotton pellet induced chronic inﬂammation in rat. Effect of free and bound
phenolic compounds of E. ofﬁcinalis on percentage inhibition of granulomatous tissue mass formation
Groups Dose (mg/kg) Wet weight(g) Dry weight (g) Difference (g) Percentage inhibition
Vehicle ? cotton – 1,011.4 ± 9.34 262.1 ± 2.5 749.3 00.00
Cotton – 1,008.5 ± 8.72 254.4 ± 1.9 754.1 00.00
DCL ? cotton 12.5 410.7 ± 5.31
a 212.1 ± 4.2
a 198.6
a 73.50
FPEO ? cotton 20 741.8 ± 7.91
b 204.5 ± 3.4
b 537.3
b 23.49
FPEO ? cotton 40 423.2 ± 6.47
a 198.3 ± 2.6
a 224.9
a 69.99
BPEO ? cotton 20 824.6 ± 5.64
b 209.3 ± 2.1
b 615.3
b 17.88
BPEO ? cotton 40 489.4 ± 4.83
a 224.2 ± 3.8
a 265.2
a 64.61
DCL diclofenac sodium, FPEO and BPEO free and bound phenolic compounds of E. ofﬁcinalis, respectively
Percentage inhibition was calculated based on the vehicle treated group values
Values are mean ± SEM (n = 6)
a p\0.05, as compared to cotton pellet treated group
b p\0.05, as compared to diclofenac sodium pretreated group
Table 2 Effect of E. ofﬁcinalis on tissue biomarker changes in cotton pellet induced chronic inﬂammation in rat. Effect of free and bound
phenolic compounds of E. ofﬁcinalis on tissue biochemical changes
Group Dose (mg/
kg)
TBARS (nmol/g of
protein)
GSH (lmol/g of
protein)
MPO (U/g of protein/
min)
Evans blue (lg/mg of
protein)
Vehicle ? cotton – 4.21 ± 0.34 0.86 ± 0.02 1.83 ± 0.14 0.164 ± 0.02
Cotton – 4.29 ± 0.29 0.82 ± 0.02 1.89 ± 0.21 0.172 ± 0.01
DCL ? cotton 12.5 2.17 ± 0.12
a 1.31 ± 0.04
a 0.42 ± 0.13
a 0.052 ± 0.03
a
FPEO ? cotton 20 3.84 ± 0.26
b 0.92 ± 0.02
b 1.47 ± 0.19
b 0.156 ± 0.01
b
FPEO ? cotton 40 2.56 ± 0.47
a 1.24 ± 0.01
a 0.56 ± 0.11
a 0.063 ± 0.02
a
BPEO ? cotton 20 4.09 ± 0.24
b 0.88 ± 0.02
b 1.64 ± 0.11
b 0.163 ± 0.05
b
BPEO ? cotton 40 2.92 ± 0.41
a 1.19 ± 0.04
a 0.81 ± 0.03
a 0.079 ± 0.03
a
DCL diclofenac, FPEO and BPEO free and bound phenolic compounds of E. ofﬁcinalis, respectively; TBARS thiobarbituric acid reactive
substances, GSH reduced glutathione, MPO myeloperoxidase
Values are mean ± SEM (n = 6)
a p\0.05, as compared to cotton pellet treated control group
b p\0.05, as compared to diclofenac sodium pretreated group
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123also expressed antiinﬂammatory action due to the presence
of free phenolic constituents (Ihantola-Vormisto et al.
1997). Hence, the results of the present work suggest that
the FPEO and BPEO fractions from the fruit of E. ofﬁci-
nalis can attenuate the acute and chronic inﬂammatory
response via antioxidant action. It may be concluded that
these effects are due to the presence of phenolic com-
pounds. However, further studies are needed to isolate the
pharmacologically active compounds and their exact
molecular mechanism to explore the antiinﬂammatory
activity.
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